LAROTRECTINIB vs LAZERTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LAROTRECTINIB vs LAZERTINIB: Safety Overview
| Metric | LAROTRECTINIB | LAZERTINIB |
|---|---|---|
| Total FAERS Reports | 798 | 352 |
| Deaths Reported | 149 | 15 |
| Death Rate | 18.7% | 4.3% |
| Hospitalizations | 151 | 83 |
| Average Patient Age | 48.9 yrs | 66.6 yrs |
| % Female Patients | 51.5% | 59.9% |
| FDA Approval Date | Nov 26, 2018 | Aug 19, 2024 |
| Manufacturer | Bayer HealthCare Pharmaceuticals Inc. | Janssen Biotech, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |